bpo gone gone gone, page-5

Reiner I don't think the Re-gen range uses Bioeffectives [Demure I can't comment], and if the substitute CGNC product achieves the same results in G-Guard [may need tinkering with dose rates]. Then they'll be good to go to market once approvals are in. I'd appreciate an update when you get a reply.

I'm wondering if SLA are funding the lawyers with that loan that slipped through the books during the year [well until it had to appear in item 14 in annual report] - not a cap raising just a loan now sitting just shy of $2M in drawdown. Just hope the big V is not going to toss it down after the 54M BPO heads that are being mooted as being dumped out of spite [me thinks V could not be that stupid and its only ignorant forum discussion].

I hold both and will watch this play out.